These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 818720)

  • 1. Sotalol in angina pectoris. A double-blind study.
    Slome R
    S Afr Med J; 1976 Mar; 50(12):469-72. PubMed ID: 818720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sotalol in the treatment of angina pectoris. A double-blind cross-over study.
    Kentala E; Pyörälä K; Frick MH
    Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of felodipine in angina pectoris.
    Lorimer AR; MacFarlane P; Pringle S; Barbour MP; Fox Y; Lawrie TD
    Eur J Clin Pharmacol; 1990; 38(5):415-9. PubMed ID: 2116311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind trial of nifedipine in angina patients with normal coronary arteries.
    Pitcher D; Sowton E
    Pharmatherapeutica; 1981; 3(1):6-13. PubMed ID: 6798584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new beta adrenergic blocking agent, sotalol, in the treatment of angina pectoris. A double blind-crossed treatment study.
    Milei J; Fortunato MR
    Rev Bras Pesqui Med Biol; 1975; 8(3-4):279-86. PubMed ID: 766118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
    Kapoor AS; Dang NS; Reynolds RD
    Clin Ther; 1985; 7(6):674-9. PubMed ID: 3935313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of sotalol, a beta-blocking agent, in patients with angina pectoris.
    Gooding PG; Berman E
    Postgrad Med J; 1974 Dec; 50(590):734-6. PubMed ID: 4157126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
    Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new beta1-selective beta-blocker H 87/07 in angina pectoris.
    Hedbäck B; Nordenfelt I; Svanström B; Vedin A; Wilhelmsson C; Oberg K
    Ann Clin Res; 1977 Oct; 9(5):305-10. PubMed ID: 28687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroderm TTS in exercise-induced angina pectoris--a randomized double-blind study.
    Colombo G; Favini G; Aglieri S; Pollavini G; de Vita C
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):211-4. PubMed ID: 3922903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral labetalol in the management of stable angina pectoris in normotensive patients.
    Upward JW; Akhras F; Jackson G
    Br Heart J; 1985 Jan; 53(1):53-7. PubMed ID: 3917674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
    Bonelli J; Gazo F; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of nisoldipine and diltiazem in the treatment of effort angina pectoris].
    de Caprio L; Sestito M; Pandolfi E; Santamaria F; di Palma A; Lombardi L; Voza A; De Rosa ML; Cicatiello AM; Rengo F
    G Ital Cardiol; 1994 Feb; 24(2):115-22. PubMed ID: 8013763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of single doses of ketanserin and placebo in chronic stable angina.
    Cameron HA; Cameron CM; Ramsay LE
    Br J Clin Pharmacol; 1986 Jul; 22(1):114-6. PubMed ID: 2874825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of nifedipine on the effort tolerance test in angina pectoris. Comparison with placebo and trinitroglycerine.
    Cherchi A; Fonzo R; Bina M
    G Ital Cardiol; 1974; 4(5):565-74. PubMed ID: 4215687
    [No Abstract]   [Full Text] [Related]  

  • 20. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.